Response of paraneoplastic syndromes to antineoplastic therapy Review


Author: Markman, M.
Review Title: Response of paraneoplastic syndromes to antineoplastic therapy
Abstract: The development of a clinically apparent paraneoplastic syndrome in a patient with malignant disease is cause for considerable concern as the symptoms can be as serious and difficult to deal with as those produced by the cancer itself. While the information in the medical literature concerning the response of paraneoplastic processes to specific antineoplastic therapy is limited, case reports and small series would suggest that a number of syndromes are alleviated with successful treatment of the underlying neoplasm. As treatment programs for advanced malignant disease improve, a larger percentage of patients suffering from the effects of paraneoplastic processes will benefit from therapy directed at their cancer.
Keywords: doxorubicin; fluorouracil; interferon; drug efficacy; methodology; dacarbazine; cyclophosphamide; hypercalcemia; cancer therapy; kidney; bone; lung carcinoma; dermatomyositis; drug therapy; paraneoplastic syndrome; therapy; nephrotic syndrome; chlorambucil; intravenous drug administration; streptozocin; hematologic diseases; endocrine system; dose time effect relation; nervous system diseases; joint; respiratory system; paraneoplastic syndromes; human; priority journal; endocrine diseases; osteoarthropathy; osteoarthropathy, secondary hypertrophic
Journal Title: Western Journal of Medicine
Volume: 144
Issue: 5
ISSN: 0093-0415
Publisher: B M J Publishing Inc  
Date Published: 1986-05-01
Start Page: 580
End Page: 585
Language: English
PUBMED: 3521097
PROVIDER: scopus
PMCID: PMC1306707
DOI/URL:
Notes: Review -- Export Date: 18 August 2021 -- Source: Scopus
Citation Impact
MSK Authors
  1. Maurie Markman
    124 Markman